WallStreetZenWallStreetZen

NASDAQ: ANIK
Anika Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Anika Therapeutics earnings were -$3.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ANIK earnings report on Jun 30, 2026 announced Q2 2026 earnings of $3.3M, down 165.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ANIK reported annual earnings of -$10.9M, with -80.7% growth.

ANIK earnings history

Current Revenue
$120.7M
Current Earnings
-$3.8M
Current Profit Margin
-3.1%

ANIK Return on Equity

Current Company
-2.7%
Current Industry
-10.1%
Current Market
28.9%
ANIK's Return on Equity (-2.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ANIK Return on Assets

Current Company
-2%
Current Industry
5.3%
ANIK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ANIK announces earnings.

ANIK Return on Capital Employed

Current Company
-2.22%
Current Industry
9.7%
ANIK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ANIK vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ANIK$3.98M-$3.78MN/A-$0.26
CV-$29.21M-$29.83MN/A-$0.45
RXST-$43.29M-$46.95MN/A-$1.13
TLSI-$21.52M-$58.68MN/A-$1.21
TMCI-$43.13M-$59.52MN/A-$0.92
View Top Medical Device Stocks

Anika Therapeutics Earnings Reports & History FAQ

What were Anika Therapeutics's earnings last quarter?

On ANIK's earnings call on Jul 29, 2026, Anika Therapeutics (NASDAQ: ANIK) reported Q2 2026 earnings per share (EPS) of $0.25, up 189.29% year over year. Total ANIK earnings for the quarter were $3.31 million. In the same quarter last year, Anika Therapeutics's earnings per share (EPS) was -$0.28.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.

Is Anika Therapeutics profitable or losing money?

As of the last Anika Therapeutics earnings report, Anika Therapeutics is currently losing money. Anika Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$3.78 million, a 93.76% decrease year over year.

What was ANIK's earnings growth in the past year?

As of Anika Therapeutics's earnings date in Jul 29, 2026, Anika Therapeutics's earnings has grown year over year. ANIK earnings in the past year totalled -$3.78 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.